Kavirajan, H; Schneider, LS (setembro de 2007). «Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.». The Lancet. Neurology. 6 (9): 782–92. PMID17689146. doi:10.1016/s1474-4422(07)70195-3
Birks, J (25 de janeiro de 2006). «Cholinesterase inhibitors for Alzheimer's disease.». The Cochrane Database of Systematic Reviews (1): CD005593. PMID16437532. doi:10.1002/14651858.CD005593
Rolinski, M; Fox, C; Maidment, I; McShane, R (14 de março de 2012). «Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.». The Cochrane Database of Systematic Reviews. 3: CD006504. PMID22419314. doi:10.1002/14651858.CD006504.pub2
Forbes, Dorothy; Forbes, Scott C.; Blake, Catherine M.; Thiessen, Emily J.; Forbes, Sean (15 de abril de 2015). «Exercise programs for people with dementia». The Cochrane Database of Systematic Reviews (4): CD006489. ISSN1469-493X. PMID25874613. doi:10.1002/14651858.CD006489.pub4
Littlejohns, Thomas J. et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology 83 September 2, 2014 American Academy of NeurologyAcesso, aosto, 2014
Kavirajan, H; Schneider, LS (setembro de 2007). «Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.». The Lancet. Neurology. 6 (9): 782–92. PMID17689146. doi:10.1016/s1474-4422(07)70195-3
Commission de la transparence (junho de 2012). «Médicaments de la maladie d'Alzheimer : à éviter» [Drugs for Alzheimer's disease: best avoided. No therapeutic advantage]. Prescrire Int. 21 (128). 150 páginas. PMID22822592
Birks, J (25 de janeiro de 2006). «Cholinesterase inhibitors for Alzheimer's disease.». The Cochrane Database of Systematic Reviews (1): CD005593. PMID16437532. doi:10.1002/14651858.CD005593
Rolinski, M; Fox, C; Maidment, I; McShane, R (14 de março de 2012). «Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.». The Cochrane Database of Systematic Reviews. 3: CD006504. PMID22419314. doi:10.1002/14651858.CD006504.pub2
Forbes, Dorothy; Forbes, Scott C.; Blake, Catherine M.; Thiessen, Emily J.; Forbes, Sean (15 de abril de 2015). «Exercise programs for people with dementia». The Cochrane Database of Systematic Reviews (4): CD006489. ISSN1469-493X. PMID25874613. doi:10.1002/14651858.CD006489.pub4
GARRIDO, REGIANE and ALMEIDA, OSVALDO P.. Distúrbios de comportamento em pacientes com demência: impacto sobre a vida do cuidador. Arq. Neuro-Psiquiatr. [online]. 1999, vol.57, n.2B [cited 2011-03-02], pp. 427–434 . Available from: <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X1999000300014&lng=en&nrm=iso>. ISSN 0004-282X. doi: 10.1590/S0004-282X1999000300014.
Forbes, Dorothy; Forbes, Scott C.; Blake, Catherine M.; Thiessen, Emily J.; Forbes, Sean (15 de abril de 2015). «Exercise programs for people with dementia». The Cochrane Database of Systematic Reviews (4): CD006489. ISSN1469-493X. PMID25874613. doi:10.1002/14651858.CD006489.pub4